WuXi AppTec(02359): WuXi Fund I intends to subscribe for a 10 million euro investment fund stake from Sofinnova Capital XI SCSp SICAV-RAIF.

WuXi AppTec (02359) announced that on November 15, 2024, its wholly-owned subsidiary WuXi PharmaTech Healthcare Fund I L.P. ("WuXi Fund I") signed a Subscription Agreement with Sofinnova Capital XI GP S. r.l. ("General Partner"), under which WuXi Fund I committed to subscribing for 10 million investment fund shares in the Sofinnova Capital XI SCSp SICAV-RAIF (the "Investment Fund"), representing approximately 4.40% of the total fund shares raised (the percentage of investment fund shares held by WuXi Fund I will be further diluted as the investment fund continues to raise additional funds). As of the date of this announcement, WuXi Fund I has not yet paid the investment funds, and will use its own funds to fulfill the payment obligation in accordance with the Subscription Agreement in the future.